Some recent studies have shown that CIS patients may present mild cognitive impairment, especially in processing speed and executive functions [4] [5] [6] . Depression and anxiety have also been found in patients with CIS but their precise prevalence in this population is still unknown [6] [7] [8] [9] . Quality of life has been studied in patients with multiple sclerosis (MS) but there are no previous studies evaluating quality of life in patients with CIS.
Several studies have showed that cognitive dysfunction, anxiety, and depression impact significantly on the quality of life of MS patients [10] [11] [12] . Considering that CIS is associated with cognitive dysfunction, depression and anxiety, it is possible that it can affect quality of life in patients with CIS. However, quality of life in patients with CIS is still poorly understood 6, 9, [13] [14] [15] . The present study aimed to evaluate the quality of life of patients with CIS and to evaluate potential determinants of quality of life such as cognition, depression and anxiety in patients with CIS.
METHODS

Subjects
Subjects aged 19-48 with CIS were recruited in the Multiple Sclerosis Clinic of Santa Casa School of Health Sciences, Vitória, Espírito Santo, Brazil. The control group was composed of healthy subjects randomly selected and paired by age, gender, and education level. The study was approved by the ethics committees of Federal University of Minas Gerais and School of Health Sciences of Santa Casa, Vitoria. Informed consent form signature was obtained from each participant. The diagnosis of CIS was done according to the following criteria: one isolated neurological episode lasting at least 24 hours compatible with demyelination of the central nervous system and magnetic resonance imaging showing at least two lesions similar to those seen in MS 1, 3 . Patients fulfilling diagnostic criteria of dissemination in time with baseline MRI were excluded 3 . Patients with severe cognitive impairment defined as score bellow 24 points in the Mini-Mental State Examination 16 or using psychotropic drugs were not included.
Quality of life, neurologic, neuropsychological, neuropsychiatric evaluation
All patients and control subjects completed the Functional Assessment of Multiple Sclerosis quality of life instrument (FAMS) 17 which is validated in Portuguese language. The neurologic evaluation included a complete history and determination of current disability using the Expanded Disability Status Scale (EDSS) 18 . Disability and activity limitations were assessed with Guy's Neurological Disability Scale (GNDS) 19 . Anxiety was evaluated with Beck Anxiety Inventory (BAI) 20, 21 . The Beck Depression Inventory (BDI) 22 was used to evaluate depression.
CIS subjects and control group were submitted to neuropsychological evaluation which included: verbal learning and verbal retention (logical memory subtest from Wechsler memory scale-revised; Rey Auditory Verbal Learning Test); visual-spatial ability (Rey Complex Figure) , information processing speed (Paced Auditory Serial Addition Test 3 and 2 seconds), working memory (Digit Span Test, Wechsler memory scale revised), executive functions (verbal fluency ' animals' and 'letter S' and Stroop's color test), and attention (D2 test; Digit Symbol).
Data analysis
Analyses were performed using 'R' software, version 2.8.0. The normality of data distribution was assessed with the Shapiro-Wilk test. Mann-Whitney test was used to compare the results of quality of life, cognitive tests, anxiety and depression symptoms between CIS patients and controls. The correlations between quality of life parameters and potential quality of life determinants including neurological disability, depression, anxiety, and cognition were evaluated in patients with CIS using the Spearman correlation test. Significance level was set at p<0.05.
RESULTS
Eighteen CIS patients were included, 13 female. The clinical and demographical data of CIS as well as the mean ± SD EDSS score of patients with CIS was 0.8±0.5 patients are shown in Table 1 . Table 2 shows the comparison of quality of life, disability, depression and anxiety between patients and controls. The cognitive evaluation showed significant differences between patients and controls in the following tests: PASAT 2 (p=0.0216) and verbal fluency with letters (p=0.0038). No differences between CIS and controls were found in the other neuropsychological tests.
In patients with CIS, there are correlations between quality of life evaluated by FAMS with cognitive tests (verbal fluency with letters and stroop card test) ( Table 3) . FAMS is not correlated with neurological disability, activity limitations, depression and anxiety (Table 3) .
DISCUSSION
Our study demonstrated reduction in the quality of life of patients with CIS. Reduced quality of life was previously demonstrated in patients with MS 23 . Considering that CIS may be the first manifestation of MS and that the neuropathological abnormalities are the same only differing in intensity and distribution it seems reasonable that CIS may affect quality of life. It is possible that the impact of MS on quality of life is higher than in CIS since MS patients usually have higher neurological disability and higher rates of depression and anxiety 9 ; however, future studies are still needed to compare the reduction in quality of life in CIS and in MS patients.
Previous studies showed that CIS patients may have impairment in memory, information processing speed, attention, semantic verbal memory, and working memory. Our findings are in line with previous studies showing neuropsychological impairment in patients with CIS [4] [5] [6] 24 . All previous studies of cognition in CIS as well as the present study showed changes in executive function evaluation, such as speed of information processing and verbal fluency 5, 6, [24] [25] [26] . There was no significant difference between BDI score of patients and controls in the present study. Previous studies have reported depression in patients with CIS 8, 11 . Di Legge et al. 27 reported depression in CIS patients with a tendency towards normalization after a relapse free period. A correlation between temporal lobe lesion load and depressive scores was previously found 27 . A possible explanation for the lack of significant reduction of CIS BDI scores compared to controls in the present study might be the low number of CIS patients not allowing a statistically significant difference to be demonstrated. Also, it was not possible to evaluate the MRI lesion sites and lesion load, and therefore it is not possible to rule out that the distribution of the lesions in this group of patients has not favored the emergence of depressive symptoms. It is also not possible to rule out that the low mean EDSS score of the CIS group explain the low depressive scores. In fact, previous studies presented a tendency to correlation between depression and disability 9 . There were higher anxiety scores in CIS patients when compared with control group. Few studies explored anxiety in CIS patients. It was shown that the severity of anxiety symptoms are related with the EDSS score and time of disease, suggesting that anxiety worsens as the disease progresses 28 . Psychological aspects have been suggested to be determinants of anxiety symptoms in patients with demyelinating diseases 29 , but there is no conclusive explanation for the causes of anxiety in CIS.
No previous studies explored quality of life determinants in CIS. In the present study we sought if neurological disability, activity limitations, cognition, depressive symptoms and anxiety had correlation with quality of life scores. Significant correlations were found between FAMS and verbal fluency with letters and Stroop's card test. Quality of life was not correlated with depression, anxiety, neurological disability and activity limitations. It has been previously shown that cognitive impairment affects quality of life in MS 12 but this is the first report showing that this occurs in CIS. 
